Assays for islet cell antibodies (ICA) are finding increasing application in clinical diabetology. We have developed a new islet cell antibody assay system (ICA-pA), whose salient features include: (1) utilization of fluorescein-conjugated staphylococcal protein A as a standard second-step reagent, the advantages of this approach being improved “signal” (islet)/“noise” (acini) ratio due to reduction of interfering background acinar pancreatic staining, and facilitation of assay standardization provided by the use of a chemically pure conjugated protein A reagent; (2) monoclonal antibody counterstaining with rhodamine-conjugated BISL-32 for the rapid identification of islets in pancreatic sections; and (3) quantitation of circulating serum ICA by microimmunofluorometric techniques.
Skip Nav Destination
Article navigation
Rapid Publications|
March 01 1985
Assay for Islet Cell Antibodies: Protein A—Monoclonal Antibody Method
S Srikanta;
S Srikanta
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Search for other works by this author on:
A Rabizadeh;
A Rabizadeh
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Search for other works by this author on:
M A K Omar;
M A K Omar
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Search for other works by this author on:
G S Eisenbarth
G S Eisenbarth
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Search for other works by this author on:
Address reprint requests to G. S. Eisenbarth, M.D., Ph.D., or S. Srikanta, M.D., Joslin Diabetes Center, Research Division, One Joslin Place, Boston, Massachusetts 02215.
Citation
S Srikanta, A Rabizadeh, M A K Omar, G S Eisenbarth; Assay for Islet Cell Antibodies: Protein A—Monoclonal Antibody Method. Diabetes 1 March 1985; 34 (3): 300–305. https://doi.org/10.2337/diab.34.3.300
Download citation file:
67
Views